Correlation Between BZAM and Medipharm Labs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BZAM and Medipharm Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BZAM and Medipharm Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BZAM and Medipharm Labs Corp, you can compare the effects of market volatilities on BZAM and Medipharm Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BZAM with a short position of Medipharm Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of BZAM and Medipharm Labs.

Diversification Opportunities for BZAM and Medipharm Labs

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between BZAM and Medipharm is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding BZAM and Medipharm Labs Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medipharm Labs Corp and BZAM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BZAM are associated (or correlated) with Medipharm Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medipharm Labs Corp has no effect on the direction of BZAM i.e., BZAM and Medipharm Labs go up and down completely randomly.

Pair Corralation between BZAM and Medipharm Labs

Assuming the 90 days horizon BZAM is expected to generate 62.89 times more return on investment than Medipharm Labs. However, BZAM is 62.89 times more volatile than Medipharm Labs Corp. It trades about 0.21 of its potential returns per unit of risk. Medipharm Labs Corp is currently generating about 0.03 per unit of risk. If you would invest  2.20  in BZAM on September 4, 2024 and sell it today you would lose (2.10) from holding BZAM or give up 95.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

BZAM  vs.  Medipharm Labs Corp

 Performance 
       Timeline  
BZAM 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in BZAM are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak primary indicators, BZAM reported solid returns over the last few months and may actually be approaching a breakup point.
Medipharm Labs Corp 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Medipharm Labs Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak forward indicators, Medipharm Labs may actually be approaching a critical reversion point that can send shares even higher in January 2025.

BZAM and Medipharm Labs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BZAM and Medipharm Labs

The main advantage of trading using opposite BZAM and Medipharm Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BZAM position performs unexpectedly, Medipharm Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will offset losses from the drop in Medipharm Labs' long position.
The idea behind BZAM and Medipharm Labs Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments